Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
J.M. Farré, M.G. Lasheras.
Factores psicológicos en la evaluación multidisciplinar de la disfunción sexual: diagnóstico y tratamiento.
Psicofármacos y función sexual, pp. 61-62
[2.]
C.h. Papadopoulos.
Sexual aspects of cardiovascular disease (Sexual medicine, vol. 10).
[3.]
Y. Drory, S. Kravetz, M. Weingarten.
Comparison of sexual activity of women and men after a first acute myocardial infarction.
Am J Cardiol, 85 (2000), pp. 1283-1287
[4.]
J. Rajfer, W.J. Aronson, P.A. Bush, F.J. Dorey, L.J. Ignarro.
Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission.
N Engl J Med, 326 (1992), pp. 90-94
[5.]
K.E. Anderson.
Pharmacology of lower urinary tract smooth muscles and penile erectile tissues.
Pharmacol Rev, 45 (1993), pp. 253-308
[6.]
O.I. Linet, F.G. Ogrinic.
for the Alprostadil Study Group. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction.
N Engl J Med, 334 (1996), pp. 873-877
[7.]
I. Goldstein, T.F. Lue, H. Padma-Nathan, R.C. Rosen, W.D. Steers, P.A. Wicker.
Oral sildenafil in treatment of erectile dysfunction.
N Engl J Med, 338 (1998), pp. 1397-1404
[8.]
H.A. Feldman, I. Goldstein, D.G. Hatzichristou, R.J. Krane, J.B. McKinlay.
Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study.
J Urol, 151 (1994), pp. 54-61
[9.]
R.F. De Busk.
Evaluating the cardiovascular tolerance for sex.
Am J Cardiol, 86 (2000), pp. 51F-56F
[10.]
J.E. Muller, A. Mittleman, M. Maclure, J.F. Sherwood, G.H. Toffler.
Triggering myocardial infarction by sexual activity. Low absolute risk and prevention by regular physical exertion. Determinants of Myocardial Infarction Study Investigators.
JAMA, 275 (1996), pp. 1405-1409
[11.]
R.A. Kloner.
A symposium: heart disease and sexual health: what do cardiologists need to know?.
Am J Cardiol, 84 (1999), pp. 1N-23N
[12.]
J.B. Kostis, H. Padma-Nathan, R.C. Rosen.
A symposium: sexual activity and cardiac risk: The Princeton Conference.
Am J Cardiol, 86 (2000), pp. 1F-68F
[13.]
R.M. Zusman.
Cardiovascular data on sildenafil citrate.
Am J Cardiol, 83 (1999), pp. 1C-44C
[14.]
M.D. Cheitlin, A.M. Hutter, R.G. Brindis, P. Ganz, S. Kaul, R.D. Russell, R.M. Zusman.
Writing Group Members. & Technology and Practice Executive Committee. Use of sildenafil (Viagra) in patients with cardiovascular disease.
[ACC/AHA Expert Consensus Document.] Circulation, 99 (1999), pp. 168-177
[15.]
H.K. Hellerstein, E.H. Friedman.
Sexual activity in the postcoronary patient.
Arch Intern Med, 125 (1970), pp. 987-999
[16.]
R.A. Stein.
The effect of exercise training on heart rate during coitus in the postmyocardiainfarction patient.
Circulation, 55 (1977), pp. 738-740
[17.]
M.A. Mittleman, M. Maclure, J.B. Sherwood, R.P. Mulry, G.H. Tofler, S.C. Jacobs, et al.
Triggering of acute myocardial infarction onset by episodes of anger.
Circulation, 92 (1995), pp. 1720-1725
[18.]
M.A. Mittleman, M. Maclure, G.H. Tofler, J.B. Sherwood, R.J. Goldberg, J.E. Muller.
for the Determinants of Myocardial Infarction Onset Study Investigators. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion.
N Engl J Med, 329 (1993), pp. 1677-1683
Copyright © 2001. Elsevier España, S.L. y Sociedad Española de Medicina Rural y Generalista (SEMERGEN)
